Tomaralimab (Anti-TLR2 / CD282)Tomaralimab (Anti-TLR2 / CD282)
Move your mouse over image or click to enlarge

Tomaralimab (Anti-TLR2 / CD282)

Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.
Cat# Size Price Qty Buy
A2333-1mg*25 1mg*25
£1,941.00
A2333-1mg*5 1mg*5
£647.00
A2333-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2333

Related Documents